McLaughlin, Martin http://orcid.org/0000-0002-9739-7133
Patin, Emmanuel C.
Pedersen, Malin
Wilkins, Anna http://orcid.org/0000-0002-0425-584X
Dillon, Magnus T.
Melcher, Alan A.
Harrington, Kevin J.
Article History
Accepted: 12 February 2020
First Online: 11 March 2020
Competing interests
: A.A.M. reports research grant funding from AstraZeneca/Medimmune, Bristol Myers Squibb and Oncolytics Biotech; and advisory board membership, honoraria and/or speakers’ bureaus from Amgen, AstraZeneca, Bristol-Myers-Squibb, Merck-Serono and Turnstone Biologics. K.J.H. reports research grant funding from AstraZeneca/Medimmune, Boehringer-Ingelheim, Merck Sharp Dohme and Replimune; and advisory board membership, honoraria and/or speakers’ bureaus from Amgen, AstraZeneca, Bristol-Myers-Squibb, Boehringer-Ingelheim, Merck-Serono, Merck Sharp Dohme, Oncolys, Pfizer and Replimune. The other authors declare no competing interests.